On March 26, 2025, Jaguar Health, Inc. entered into agreements to issue approximately $3.4 million in convertible promissory notes to accredited investors, which will close around March 27, 2025, for working capital. The notes bear 6% interest and can be converted into about 622,598 shares of common stock at specified prices.